Summary: Clinicians are faced with complex decisions regarding optimal adjuvant treatment of ER-positive breast cancer in pre- and post-menopausal women.
Summary: Clinicians are faced with complex decisions regarding optimal adjuvant treatment of ER-positive breast cancer in pre- and post-menopausal women.